Gay News From Around The Globe

New Three-in-One HIV Med Complera Approved

The Food and Drug Administration has approved a new combination therapy for HIV.

Complera, a complete single-tablet regimen containing Janssen Therapeutics’ Edurant (rilpivirine) and Gilead Sciences’ Viread (tenofovir) and Emtriva (emtricitabine), was approved August 10 by the U.S. Food and Drug Administration (FDA), according to an announcement by Gilead. Complera, the second all-in-one fixed-dose combination tablet for people living with HIV, is approved for those starting antiretroviral (ARV) therapy for the first time.

Source POZ

Tags

Related Articles

What do you think?

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Close